-
Lurbinectedin Superior to Topotecan for Treating SCLC
18 Apr 2024 07:54 GMT
In a recent publication in Lung Cancer, data from a post hoc … a subgroup of small cell lung cancer (SCLC) patients from the BASKET … or in combination with irinotecan versus topotecan or irinotecan in the population …
-
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
18 Apr 2024 07:34 GMT
… vice-versa.22
Alternatively, nanoliposomal irinotecan (NAL-IRI) + 5-fluorouracil … in non small cell lung cancer. Both are small molecules … in non-small cell lung cancer, in the context of … pathways: targeting NRG1 fusions in lung cancer. Clin Cancer Res. 2015 …
-
Prognostic Nutritional Index Predicts Efficacy and Immune-Related Adverse Events of First-Line Chemoimmunotherapy in Patients with Extensive-Stage Small-Cell Lung Cancer
18 Mar 2024 13:18 GMT
… for Small-Cell Lung Cancer Patients
Association Between … Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, … M, et al. Irinotecan plus cisplatin compared with … metastatic small-cell lung cancer (SCLC). Lung Cancer. 2004;45 Suppl …
-
Ramucirumab by Eli Lilly and Co for Gallbladder Cancer: Likelihood of Approval
18 Apr 2024 03:41 GMT
… in combination with FOLFIRI (irinotecan, folinic acid, and 5 … non-small cell lung cancer with activating epidermal … squamous non-small cell lung cancer, metastatic colorectal cancer, … gallbladder cancer, small-cell lung cancer and metastatic thymic carcinoma …
-
Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer
07 Feb 2024 12:27 GMT
… to date, including lung cancer, bladder cancer, esophageal … response (MPR).
About Lung Cancer
Lung cancer is the leading … fluoropyrimidine, oxaliplatin, and irinotecan. This indication is … lung cancer; Checkmate 816-neoadjuvant non-small cell lung cancer, …
-
NuCana Announces Completion of ADS Ratio Change
16 Apr 2024 12:00 GMT
… :302) in combination with leucovorin, irinotecan or oxaliplatin, and bevacizumab in … :323) in combination with leucovorin, irinotecan, and bevacizumab for the second … with docetaxel for patients with lung cancer. NUC-7738 is a transformation …
-
Sacituzumab Tirumotecan Shows Early Efficacy in Gastric/GEJ Cancers
15 Apr 2024 17:10 GMT
… , non–small cell lung cancer, gastric adenocarcinoma, small cell lung cancer, and urothelial carcinoma … patients previously were treated with irinotecan.
An international phase 3 trial …
-
Neoadjuvant Opdivo (nivolumab) with Chemotherapy Provides Benefits for Patients with Resectable Non-Small Cell Lung Cancer Across PD-L1 Expression Levels with Three-Year Follow Up in CheckMate -816 Trial
17 Oct 2023 20:05 GMT
… tumor types, including lung cancer, bladder cancer, esophageal … distant metastases.
About Lung Cancer
Lung cancer is the leading … fluoropyrimidine, oxaliplatin, and irinotecan. This indication is … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer …
-
Perioperative Regimen of Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Adjuvant Opdivo Shows Significant Improvement in Event-Free Survival for Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -77T Trial
17 Oct 2023 19:36 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … response (MPR).
About Lung Cancer
Lung cancer is the leading … fluoropyrimidine, oxaliplatin, and irinotecan. This indication is … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
12 Oct 2023 11:00 GMT
… medicines to patients with lung cancer. By pursuing precision medicines … Non-Small Cell Lung Cancer (NSCLC)
Lung cancer is the second … 85% of all lung cancers.5
Certain lung cancers are linked to … with cetuximab compared to irinotecan with cetuximab or FOLFIRI …